Richard A. Miller - 31 Dec 2024 SCHEDULE 13G/A Report for Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS)

Filing Manager
Richard A. Miller
Reporting Manager
Richard A. Miller
Security
Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
CRVS
Shares outstanding
67,796,987 shares
Disclosed Ownership
5,220,368 shares
Ownership
7.7%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 16:30:02 UTC
Date of event
31 Dec 2024
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Richard A. Miller 7.7% 5,220,368 3,454,631 1,765,737 /s/ Richard A. Miller Richard A. Miller
Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 2.7% 1,765,737 0 1,765,737 /s/ Richard A. Miller Richard A. Miller, Trustee
Sandra J. Horning 2.7% 1,765,737 0 1,765,737 /s/ Richard A. Miller Richard A. Miller, Authorized Signatory